AbD Serotec, a research and diagnostic division of MorphoSys AG of Martinsried, Germany, and its customer e2v biosensors, a subsidiary of e2v technologies plc of Essex, UK, have developed Visucare, a biosensor program that can identify biomarkers with a single-antibody immunoassay. The system will be combined with AbD Serotec’s HuCAL antibody technology to analyze protein quantification for patient care. E2v technologies is a manufacturer of sensors and semiconductors, and MorphoSys researches antibody technology.